Location History:
- Zhejiang, CN (2017)
- Shanghai, CN (2018)
- Hangzhou, CN (2016 - 2022)
Company Filing History:
Years Active: 2016-2022
Title: Innovations by Inventor Qinghua Xu in Bladder Cancer and Medulloblastoma Detection
Introduction: Qinghua Xu, a distinguished inventor based in Hangzhou, China, has made significant contributions to the fields of cancer detection and classification through his innovative research and patented technologies. With a total of seven patents to his name, Qinghua Xu's work is dedicated to advancing medical diagnostics and improving patient outcomes.
Latest Patents: Among his latest innovations, one of the noteworthy patents is the "Set of genes for bladder cancer detection and use thereof." This invention discloses a set of 32 genes, including CA9, CDK1, CTSE, and others. The kit developed from this patent offers a non-invasive method for bladder cancer detection with high accuracy and objective interpretation of results. Its clinical significance lies in facilitating early detection and postoperative monitoring of bladder cancer, with improved patient compliance compared to traditional cystoscopy methods.
Another significant invention is the "Set of genes for molecular classifying of medulloblastoma and use thereof." This patent encompasses 24 genes, such as EPHA7, OTX2, and ROBO1, which are crucial for the molecular classification of medulloblastoma. The technology enables accurate differentiation of various medulloblastoma subgroups, providing essential insights for precise treatment options, underscored by its objective results and reduced experimental time.
Career Highlights: Qinghua Xu has worked with prestigious companies such as Biomerieux, Inc., and Hangzhou Canhelp Genomics Technology Co. Ltd. His experience in these organizations has undoubtedly contributed to his innovative research and the development of his patented technologies.
Collaborations: Throughout his career, Xu has collaborated with notable individuals, including Xun Ye and Fei Wu. These professional relationships have fostered an environment of innovation and collaboration, allowing for the advancement of significant medical technologies.
Conclusion: Qinghua Xu's contributions to the field of cancer diagnostics through his patents and innovative research play a vital role in enhancing medical practices. His work not only aids in the early detection and classification of cancers but also improves the overall efficiency and effectiveness of treatment options for patients. As cancer research continues to evolve, inventors like Qinghua Xu pave the way for breakthroughs that can transform healthcare and save lives.